Evonik and HosenCare officially announced the launch of a new China-focused innovation fund—Jinjiang Houxin—during the 8th China International Import Expo. The fund is jointly initiated with multiple partners to deepen local innovation collaboration and accelerate the commercialization of high-quality, sustainable technologies in China. ... MORE
In an environment of high uncertainty and weak demand, Evonik generated adjusted EBITDA of €448 million in the third quarter of 2025 ─ 22 percent below the robust prior-year results (Q3 2024: €577 million) and within the expected range of €420 million to €460 million as communicated on September 25. ... MORE
Evonik has launched the new Noblyst® F catalyst portfolio, specifically designed for flow applications. This cutting-edge range is set to revolutionize processes and deliver superior performance for customers. ... MORE
Evonik has launched the new Noblyst® F catalyst portfolio, specifically designed for flow applications. This cutting-edge range is set to revolutionize processes and deliver superior performance for customers. ... MORE
Evonik has officially opened its first state-of-theart fumed alumina production facility “Alu5” in Yokkaichi, Japan, which marks a major step forward in the company’s strategy to serve the Asian market with advanced aluminum oxide-based solutions. ... MORE
Evonik’s EUDRACAP® colon functional capsules are now available produced under good manufacturing practice (GMP). ... MORE
